GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (STU:B9A) » Definitions » Policy Acquisition Expense

BioArctic AB (STU:B9A) Policy Acquisition Expense


View and export this data going back to 2020. Start your Free Trial

What is BioArctic AB Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


BioArctic AB (STU:B9A) Business Description

Industry
Traded in Other Exchanges
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.